• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ciprofloxacin pharmacokinetics in critically ill patients receiving concomitant continuous venovenous hemodialysis.

作者信息

Shotwell Matthew S, Madonia Phillip N, Connor Michael J, Amde Milen, Salem Charbel, Aduroja Olufemi A, Bauer Seth R, Groszek Joseph J, Fissell William H

机构信息

Vanderbilt University, Nashville, Tennessee.

Emory University, Atlanta, Georgia.

出版信息

Am J Kidney Dis. 2015 Jul;66(1):173-5. doi: 10.1053/j.ajkd.2015.03.001. Epub 2015 Apr 23.

DOI:10.1053/j.ajkd.2015.03.001
PMID:25912840
Abstract
摘要

相似文献

1
Ciprofloxacin pharmacokinetics in critically ill patients receiving concomitant continuous venovenous hemodialysis.接受连续性静脉-静脉血液透析的危重症患者的环丙沙星药代动力学
Am J Kidney Dis. 2015 Jul;66(1):173-5. doi: 10.1053/j.ajkd.2015.03.001. Epub 2015 Apr 23.
2
Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis.重症患者连续静脉-静脉血液透析时的达托霉素药代动力学。
Crit Care Med. 2011 Jan;39(1):19-25. doi: 10.1097/CCM.0b013e3181fa36fb.
3
Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.比较连续静脉-静脉血液滤过和血液透析滤过在危重症患者中对环丙沙星群体药代动力学的影响。
J Antimicrob Chemother. 2016 Jun;71(6):1643-50. doi: 10.1093/jac/dkw043. Epub 2016 Mar 7.
4
An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration.对接受持续静脉-静脉血液透析滤过的危重症患者环丙沙星药代动力学的评估。
BMC Clin Pharmacol. 2011 Aug 4;11:11. doi: 10.1186/1472-6904-11-11.
5
Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis.急性肾衰竭患者在接受持续静脉-静脉血液滤过治疗时环丙沙星的药代动力学：合并肝硬化的影响
Acta Med Austriaca. 2002;29(3):112-6. doi: 10.1046/j.1563-2571.2002.02017.x.
6
Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches.环丙沙星在重症患者中的应用：药代动力学和药效学方法
Int J Antimicrob Agents. 2008 Dec;32(6):505-10. doi: 10.1016/j.ijantimicag.2008.05.019. Epub 2008 Sep 2.
7
Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study.危重症患者的环丙沙星药代动力学：一项前瞻性队列研究。
J Crit Care. 2008 Sep;23(3):422-30. doi: 10.1016/j.jcrc.2007.11.011. Epub 2008 Apr 18.
8
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.连续性肾脏替代治疗的危重症患者的抗生素浓度变异性：一项多中心药代动力学研究。
Crit Care Med. 2012 May;40(5):1523-8. doi: 10.1097/CCM.0b013e318241e553.
9
Effect of Multi Drug Resistance Protein 4 (MRP4) Inhibition on the Pharmacokinetics and Pharmacodynamics of Ciprofloxacin in Normal and Rats with LPS-Induced Inflammation.多药耐药蛋白4（MRP4）抑制对环丙沙星在正常大鼠和脂多糖诱导炎症大鼠体内药代动力学和药效学的影响。
Eur J Drug Metab Pharmacokinet. 2016 Dec;41(6):733-741. doi: 10.1007/s13318-015-0302-5.
10
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective.在医院环境中，环丙沙星单药治疗应采用哪种可靠的药效学断点？基于治疗药物监测的回顾性观点。
J Antimicrob Chemother. 2006 Aug;58(2):380-6. doi: 10.1093/jac/dkl226. Epub 2006 May 30.

引用本文的文献

1
Pharmacokinetics of ciprofloxacin during continuous renal replacement therapy in intensive care patients - new assessment.重症监护患者连续性肾脏替代治疗期间环丙沙星的药代动力学-新评估。
Anaesthesiol Intensive Ther. 2020;52(4):267-273. doi: 10.5114/ait.2020.99605.
2
Pharmacokinetic and Pharmacodynamic Considerations of Antibiotics of Last Resort in Treating Gram-Negative Infections in Adult Critically Ill Patients.成人重症患者革兰阴性菌感染治疗中使用的最后手段抗生素的药代动力学和药效学考量
Curr Infect Dis Rep. 2018 Apr 5;20(5):10. doi: 10.1007/s11908-018-0614-0.